Update: Management of Parapneumonic Effusions

Clinical Pulmonary Medicine

Volumn 10, Issue 6, 2003, Pages 336-342

  Light, Richard W ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b SAINT THOMAS HOSPITAL   (United States)

Author keywords

Decortication; Empyema; Fibrinolytics; Parapneumonic effusion; Pleural effusion; Thoracoscopy

Indexed keywords

AMINOGLYCOSIDE; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; DORNASE ALFA; FIBRINOLYTIC AGENT; GATIFLOXACIN; GLUCOSE; LACTATE DEHYDROGENASE; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTODORNASE; STREPTODORNASE PLUS STREPTOKINASE; STREPTOKINASE; UROKINASE;

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; CLINICAL TRIAL; DECORTICATION; DIAPHRAGM; DRUG COST; ECHOGRAPHY; EMPYEMA; FEVER; FIBRINOLYSIS; GRAM STAINING; HOSPITALIZATION; HUMAN; LEUKOCYTOSIS; MALAISE; NONHUMAN; PARAPNEUMONIC EFFUSION; PH; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PUS; REVIEW; SAMPLING; SIDE EFFECT; THORACOCENTESIS; THORACOSCOPY; THORACOTOMY; THORAX DRAINAGE; THORAX RADIOGRAPHY; TUBE;

EID: 1542314780     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000097786.04703.66     Document Type: Review

References (53)

1. Neiderman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993;148:1418-1426.
2. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med. 1980;69:507-511.
3. Musher DM, Alexandraki I, Graviss EA, et al. Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study. Medicine (Baltimore). 2000;79:210-221.
4. Hasley PB, Albaum MN, Li Y-H, et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med. 1996;156:2206-2212.
5. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. JAMA. 1996;275:134-141.
6. Broaddus VC. Infections in the pleural space: an update on pathogenesis and management. Semin Respir Crit Card Med. 1995;16:303-314.
7. 2. Chest. 1973;64:591-596.
8. Andrews NC, Parker EF, Shaw RR, et al. Management of nontuberculous empyema. Am Rev Respir Dis. 1962;85:935-936.
9. Wiener-Kronish JP, Sakuma T, Kudoh I, et al. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol. 1993;75:1661-1669.
10. Light RW. Pleural Diseases. 4th edition. Baltimore: Lippincott Williams & Wilkins; 2001.
11. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118:1158-1171.
12. Cheng D-S, Rodriguez RM, Rogers J, et al. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest. 1998;114:1368-1372.
13. Teixeira LR, Sasse SA, Villarino MA, et al. Antibiotics levels in empyemic pleural fluid. Chest. 2000;117:1734-1739.
14. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med. 2001;163:1730-1754.
15. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis. 1974;110:56-77.
16. Cham CW, Haq SM, Rahamim J. Empyema thoracis: a problem with late referral? Thorax. 1993;48:925-927.
17. Bowditch HI. Paracentesis thoracic: an analysis of 25 cases of pleuritic effusion. Am Med Monthly. 1853;3-45.
18. Snider GL, Saleh SS. Empyema of the thorax in adults: review of 105 cases. Chest. 1968;54:12-17.
19. Sasse S, Nguyen T, Teixeira LR, et al. The utility of daily therapeutic thoracentesis for the treatment of early empyema. Chest. 1999;116:1703-1708.
20. Storm HKR, Krasnik M, Bang K, et al. Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax. 1992;47:821-824.
21. Simmers TA, Jie C, Sie B. Minimally invasive treatment of thoracic empyema. Thorac Cardiovasc Surg. 1999;47:77-81.
22. Shankar S, Gulati M, Kang M, et al. Image-guided percutaneous drainage of thoracic empyema: can sonography predict the outcome? Eur Radiol. 2000;10:495-499.
23. Ali I, Unruh H. Management of empyema thoracis. Ann Thorac Surg. 1990;50:355-359.
24. Ashbaugh DG. Empyema thoracis: factors influencing morbidity and mortality. Chest. 1991;99:1162-1165.
25. Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodomase in the treatment of postpneumonic empyema. J Thorac Surg. 1951;21:275-297.
26. Light RW, Nguyen T, Mulligan ME, et al. The in vitro efficacy of Varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung. 2000;178:13-18.
27. Bergh NP, Ekroth R, Larsson S, et al. Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg. 1977;11:265-268.
28. Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291-295.
29. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest. 1996;109:1514-1519.
30. Laisaar T, Puttsepp E, Laisaar V. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas. Thorac Cardiovasc Surg. 1996;44:252-256.
31. Temes RT, Follis F, Kessler RM, et al. Intrapleural fibrinolytics in management of empyema thoracis. Chest. 1996;110:102-106.
32. Moulton JS, Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase. Am J of Roentgenol. 1989;153:941-945.
33. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med. 1998;157:328-330.
34. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest. 1997;111:275-279.
35. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416-421.
36. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37-42.
37. Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658-660.
38. Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J. 1999;13:514-518.
39. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000;117:1728-733.
40. Silen ML, Naunheim KS. Thoracoscopic approach to the management of empyema thoracis: indications and results. Chest Surg Clin North Am. 1996;6:491-499.
41. Landreneau RJ, Keenan RJ, Hazelrigg SR, et al. Thoracoscopy for empyema and hemothorax. Chest. 1995;109:18-24.
42. Cassina PC, Hauser M, Hillejan L, et al. Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome. J Thorac Cardiovasc Surg. 1999;117:234-238.
43. Lawrence DR, Ohri SK, Moxon RE, et al. Thoracoscopic debridement of empyema thoracis. Ann Thorac Surg. 1997;64:1448-1450.
44. Striffeler H, Gugger M, Im HV, et al. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg. 1998;65:319-323.
45. Wait MA, Sharma S, Hohn J, et al. A randomized trial of empyema therapy. Chest. 1997;111:1548-551.
46. Thurer RJ. Decortication in thoracic empyema: indications and surgical technique. Chest Surg Clin North Am. 1996;6:461-490.
47. Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest. 1994;105:832-836.
48. Angelillo Mackinlay TA, Lyons GA, Chimondeguy DJ, et al. VATS debridement versus thoracotomy in the treatment of loculated postpneumonia empyema. Ann Thorac Surg. 1996;61:1626-1630.
49. Neff CC, vanSonnenberg E, Lawson DW, et al. CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage. Radiology. 1990;176:195-197.
50. Rzyman W, Skokowski J, Romanowicz G, et al. Decortication in chronic pleural empyema: effect on lung function. Eur J Cardiothorac Surg. 2002;21:502-507.
51. Maruyama R, Ondo K, Mikami K, et al. Clinical course and management of patients undergoing open window thoracostomy for thoracic empyema. Respiration. 2001;68:606-610.
52. Empyema Commission. Cases of empyema at Camp Lee, Virginia. JAMA. 1918;71:366-373.
53. Waller DA, Rengarajan A. Thoracoscopic decortication: a role for video-assisted surgery in chronic postpneumonic pleural empyema. Ann Thorac Surg. 2001;71:1813-1816.